ArticleEuropean journal of orthopaedic surgery & traumatology : orthopedie traumatologie2026
Association of GLP-1 receptor agonist use with outcomes after surgical fixation of femoral neck fracture in patients with type 2 diabetes: a propensity score-matched analysis.
Article in European journal of orthopaedic surgery & traumatology : orthopedie traumatologie, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
purposeGlucagon-like peptide-1 receptor agonists (GLP-1RA) improve glycemic control and support weight management in type 2 diabetics, but their safety during the perioperative period in fracture surgery remains unclear. We hypothesized that preoperative use of GLP-1RA would not increase postoperative complications after surgical fixation of femoral neck fractures.
methodsWe conducted a retrospective propensity score–matched cohort study within an integrated United States health system. Adults with type 2 diabetes undergoing open reduction and internal fixation or closed reduction and percutaneous pinning for AO OTA 31B femoral neck fractures from 2016 to 2023 were included. Exposure was active GLP-1RA use at admission. Matching was 1:2 on age, sex, body mass index, smoking status, and Elixhauser Comorbidity Index. Primary outcomes were aspiration pneumonitis and composite medical complications at 30, 90, and 365 days. Secondary outcomes were implant failure, nonunion, malunion, revision surgery, and mortality.
resultsWe matched 112 GLP-1RA users to 224 patients not using a GLP-1RA. Aspiration pneumonitis was not significantly different (1.8% vs. 2.2%, P = .790). There were no significant differences in length of stay (P = .256), time to surgery (P = .965), ACE (30/90/365-day P > .80), composite medical complications at 30, 90, or 365 days (all P ≥ .363), or mortality/discharge to hospice through 365 days (P = .120). Revision surgery within 365 days occurred in 0% of GLP-1RA users vs. 4.5% in nonusers (P = .063). DISCUSSION: Preoperative GLP-1RA use was not associated with higher perioperative morbidity or mortality after femoral neck fracture fixation and may be linked to fewer reoperations. Larger multicenter studies are warranted. LEVEL OF EVIDENCE: III, retrospective cohort.
Indexed as
Identifiers
41870668What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.